BlackRock Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$13K Hold
1,212
﹤0.01% 3534
2016
Q3
$21K Sell
1,212
-7,131
-85% -$132K ﹤0.01% 3438
2016
Q2
$182K Buy
8,343
+443
+6% +$7.97K ﹤0.01% 2663
2016
Q1
$151K Hold
7,900
﹤0.01% 2699
2015
Q4
$221K Sell
7,900
-1,825
-19% -$51.6K ﹤0.01% 2514
2015
Q3
$237K Sell
9,725
-240
-2% -$5.74K ﹤0.01% 2619
2015
Q2
$232K Buy
+9,965
New +$182K ﹤0.01% 2719

Other funds holding IRMD

BlackRock Advisors's IRMD Position: Q4 2016 in Review

BlackRock Advisors held its iRadimed (IRMD) position steady in Q4 2016 at 1,212 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

BlackRock Advisors first reported a position in IRMD in Q2 2015 and has held it in 7 quarters since. The position peaked at $237K in Q3 2015. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • BlackRock Advisors held 1,212 shares of iRadimed worth $13K as of Q4 2016.
  • BlackRock Advisors left its iRadimed share count unchanged in Q4 2016.
  • iRadimed made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3534 holding.
  • BlackRock Advisors first reported a position in iRadimed in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's iRadimed position peaked at $237K in Q3 2015.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.